Test your 2020 influenza vaccine knowledge with our quiz!

We have developed a short quiz about the available 2020 influenza vaccines! Check your knowledge of the 2020 influenza recommendations and vaccines here:

MVEC 2020 Influenza vaccine quiz

Our 2020 influenza vaccine resources can be found here:

Why vaccination against polio is important

A Nigerian father who opposed vaccinations prior to his son contracting polio now campaigns for vaccines, lending his support and voice to local health workers. 
The PAEDS (Paediatric Active Enhanced Disease Surveillance) network funded by the Australian Government Department of Health monitors childhood conditions of public health importance. One of the current childhood conditions being monitored is Acute Flaccid Paralysis (AFP), a condition causing paralysis and loss of tone in one or more limbs, which can be caused by the polio virus. Find out more about the PAEDS network on our PAEDS reference page

Introduction of Gardasil 9

With the transition from Gardasil® to Gardasil 9® on the National Immunisation Program in January 2018, MVEC has created a new Immunisation Reference page on Human Papilloma Virus (HPV). Please follow the link for details MVEC: Human Papilloma Virus (HPV)

Interesting SAEFVIC education articles

We have created a new immunisation reference page containing interesting case studies and other educational articles written by SAEFVIC and published in the Department of Health newsletter.

For more information please follow the link to our website SAEFVIC education articles


New Measles Alert

Measles is a highly contagious disease that causes skin rash and fever. (In severe cases, it can lead to sometimes fatal complications such as pneumonia and brain inflammation.)

Melbourne is experiencing increased measles activity—several children have been admitted to the RCH, and cases have occurred in returned travellers.

Anyone who hasn’t been immunised is at high risk of infection—particularly children and healthcare workers.

To help stop the spread of measles, please share this information:

  • Immunisation is the best protection against measles.
  • Under the National Immunisation Program, a 1st measles vaccine dose is recommended at 12 months of age.  A 2nd routine dose is recommended either at 18 months of age or 3.5 to 4 years of age (depending on date of birth).
  • If parents request an early second dose for their child (for example, because they are aged between 13 months and 4 years), a second dose can be provided at least one month after the initial dose.
  • The second dose will be MMR-Varicella (MMRV) or MMR (for children that have previously received a funded monovalent Varicella vaccine at 18 months of age).
  • Whilst there is no active recalling of patients for measles vaccinations, 2nd measles doses administered early are government funded and will be accepted as valid doses by the Australian Childhood Immunisation Register (ACIR).
  • If you are unsure about your child’s vaccination history or your own immunity, check your immunisation records and/or contact your general practitioner.
  • Additional measles vaccine doses for adults require a prescription.

For more information contact the RCH Immunisation Centre on (03) 9345 6599 or 1300 882 924.

Further resources can be found at:

Victorian Department of Health: Measles News release

JABBED documentary re-screening Sunday 13th July at 8:30pm on SBS

JABBED was made by Emmy Award-winning Australian documentary filmmaker Sonya Pemberton, who travelled the globe to look at the real science behind vaccinations, tracks real epidemics, and investigates the real cost of opting out. The film poses the potent question: what would you do to protect the ones you love?

First released in 2013, the JABBED documentary has been one of the most watched shows in the history of SBS television and is re-screening on Sunday July 13th 2014 at 8:30pm.

It includes highlighting the impact of pertussis (‘whooping cough’) on a child and their family, following an admission to The Royal Children’s Hospital Melbourne.